OTC Markets EXMKT - Delayed Quote USD
Affymax, Inc. (AFFY)
0.0008
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Mark G. Thompson | CFO & Secretary | 97.49k | -- | 1962 |
| Mr. Jonathan M. Couchman CFA | CEO, President & Director | -- | -- | 1970 |
| Dr. Tracy J. Dunn Ph.D., J.D. | Vice President of Intellectual Property & Legal Affairs | -- | -- | 1963 |
Affymax, Inc.
630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Corporate Governance
Affymax, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
December 23, 2014 at 12:00 AM UTC
Dividend Date
November 28, 2014 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
NNBP Nanobac Pharmaceuticals, Incorporated
0.0001
0.00%
ROTH PharmaRoth Labs, Inc.
0.0001
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
NBY NovaBay Pharmaceuticals, Inc.
0.5772
-1.27%
OGEN Oragenics, Inc.
0.1940
+3.74%
GALT Galectin Therapeutics Inc.
1.3400
+0.75%
TH.TO Theratechnologies Inc.
3.7350
-1.45%
RLMD Relmada Therapeutics, Inc.
0.6900
+82.54%
VIR Vir Biotechnology, Inc.
5.97
+2.93%